NEA Management Company, LLC - TRACON PHARMACEUTICALS INC ownership

TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 46 filers reported holding TRACON PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.76 and the average weighting 0.1%.

Quarter-by-quarter ownership
NEA Management Company, LLC ownership history of TRACON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$579,000
-16.5%
346,7190.0%0.03%
-19.4%
Q2 2022$693,000
-24.0%
346,7190.0%0.04%
+38.5%
Q1 2022$912,000
-5.0%
346,719
+0.0%
0.03%
+36.8%
Q4 2021$960,000
-28.5%
346,7180.0%0.02%
+18.8%
Q3 2021$1,342,000
-40.4%
346,7180.0%0.02%
-44.8%
Q2 2021$2,250,000
-92.1%
346,7180.0%0.03%
-95.5%
Q1 2021$28,535,000
+603.4%
346,7180.0%0.64%
+498.1%
Q4 2020$4,057,000
+126.3%
346,7180.0%0.11%
+40.8%
Q3 2020$1,793,000
+163.7%
346,7180.0%0.08%
+181.5%
Q2 2020$680,000
+15.4%
346,7180.0%0.03%
-12.9%
Q1 2020$589,000346,7180.03%
Other shareholders
TRACON PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Opaleye Management Inc. 2,518,371$16,344,0002.72%
Ikarian Capital, LLC 2,716,840$17,631,0001.42%
Telemetry Investments, L.L.C. 40,000$260,0000.36%
ACT CAPITAL MANAGEMENT, LLC 28,500$185,0000.10%
Vigilare Wealth Management 17,000$110,0000.07%
X-Square Capital, LLC 20,973$136,0000.06%
BOOTHBAY FUND MANAGEMENT, LLC 294,031$1,908,0000.06%
Johnson & Johnson Innovation - JJDC, Inc. 84,003$545,0000.06%
NEA Management Company, LLC 346,718$2,250,0000.03%
GSA CAPITAL PARTNERS LLP 36,370$236,0000.03%
View complete list of TRACON PHARMACEUTICALS INC shareholders